Select Clinical Trial
Protocol Number: NRG HN009
Protocol Title: Randomized phase II/III trial of radiation with high-does Cisplatin (100 mg/m²) every three weeks versus radiation with low-does weekly Cisplatin (40 mg/m²) for patients with locoregionally advanced squamous cell carcinoma of the head and neck.
Eligibility: Men or women age 18 and older with squamous cell cancer of the head and neck without distant metastasis.
Contact Information: (910) 715-2200